Shkreli Gets Snow Day as Congress Delays Hearing After Storm
- Tuesday hearing delayed to Feb. 4, Shkreli lawyers says
- Valeant interim CEO Schiller was also scheduled to testify
Meet Martin Shkreli, Internet Star
This article is for subscribers only.
Former pharmaceutical executive Martin Shkreli will have more time to battle a congressional subpoena after lawmakers postponed a hearing on U.S. drug prices because of a major snowstorm over the weekend.
The House Committee on Oversight and Government Reform will now hold the hearing, which was originally scheduled for Tuesday, on Feb. 4, according to a letter from Shkreli’s lawyers sent Monday to a judge in Brooklyn. MJ Henshaw, a spokeswoman for Committee Chairman and Utah Republican Jason Chaffetz, didn’t immediately respond to an e-mail seeking to confirm the date.